Literature DB >> 20042631

Prevalence and associations of tcpC, a gene encoding a Toll/interleukin-1 receptor domain-containing protein, among Escherichia coli urinary tract infection, skin and soft tissue infection, and commensal isolates.

Marjanca Starcic Erjavec1, Blaz Jesenko, Ziva Petkovsek, Darja Zgur-Bertok.   

Abstract

TcpC, a new Toll/interleukin-1 receptor domain-containing protein of uropathogenic Escherichia coli involved in the suppression of innate immunity, was found in 2008. The aim of the present study was to determine the prevalence of tcpC and its association with virulence factors and phylogenetic groups among strains from a collection of 212 E. coli isolates from urinary tract and skin and soft tissue infections and 90 commensal E. coli strains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042631      PMCID: PMC2832412          DOI: 10.1128/JCM.01227-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.

Authors:  T A Russo; J R Johnson
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

2.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

3.  Virulence determinants of uropathogenic Escherichia coli in fecal strains from intestinal infections and healthy individuals.

Authors:  I Kuhar; M Grabnar; D Zgur-Bertok
Journal:  FEMS Microbiol Lett       Date:  1998-07-15       Impact factor: 2.742

4.  Structural and sequence diversity of the pathogenicity island of uropathogenic Escherichia coli which encodes the USP protein.

Authors:  M Nakano; S Yamamoto; A Terai; O Ogawa; S I Makino; H Hayashi; G B Nair; H Kurazono
Journal:  FEMS Microbiol Lett       Date:  2001-11-27       Impact factor: 2.742

5.  A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(alpha 1-4)Gal-binding PapG adhesins of Escherichia coli.

Authors:  J R Johnson; J J Brown
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

6.  Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.

Authors:  J R Johnson; A L Stell
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

7.  Virulence potential of Escherichia coli isolates from skin and soft tissue infections.

Authors:  Ziva Petkovsek; Kristina Elersic; Marija Gubina; Darja Zgur-Bertok; Marjanca Starcic Erjavec
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

8.  Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction.

Authors:  S Yamamoto; A Terai; K Yuri; H Kurazono; Y Takeda; O Yoshida
Journal:  FEMS Immunol Med Microbiol       Date:  1995-10

9.  Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction.

Authors:  C Le Bouguenec; M Archambaud; A Labigne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  8 in total

1.  Escherichia coli isolated from feces of brown bears (Ursus arctos) have a lower prevalence of human extraintestinal pathogenic E. coli virulence-associated genes.

Authors:  Maruša Vadnov; Damjana Barbič; Darja Žgur-Bertok; Marjanca Starčič Erjavec
Journal:  Can J Vet Res       Date:  2017-01       Impact factor: 1.310

2.  A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signaling.

Authors:  Fatemeh Askarian; Nina M van Sorge; Maria Sangvik; Federico C Beasley; Jørn R Henriksen; Johanna U E Sollid; Jos A G van Strijp; Victor Nizet; Mona Johannessen
Journal:  J Innate Immun       Date:  2014-01-25       Impact factor: 7.349

Review 3.  Immunomodulation therapy offers new molecular strategies to treat UTI.

Authors:  Daniel Butler; Ines Ambite; Murphy Lam Yim Wan; Thi Hien Tran; Björn Wullt; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2022-06-22       Impact factor: 16.430

Review 4.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

5.  Escherichia coli Affects Expression of Circadian Clock Genes in Human Hepatoma Cells.

Authors:  Urša Kovač; Zala Žužek; Lucija Raspor Dall'Olio; Katka Pohar; Alojz Ihan; Miha Moškon; Damjana Rozman; Marjanca Starčič Erjavec
Journal:  Microorganisms       Date:  2021-04-17

6.  Complete sequence of classic F-type plasmid pRK100 shows unique conservation over time and geographic location.

Authors:  Marjanca Starčič Erjavec; Karmen Jeseničnik; Lauren P Elam; Andrej Kastrin; Luka Predojević; Tatyana A Sysoeva
Journal:  Plasmid       Date:  2022-01-22       Impact factor: 3.085

7.  A Biomimetic Porcine Urothelial Model for Assessing Escherichia coli Pathogenicity.

Authors:  Luka Predojević; Darja Keše; Darja Žgur Bertok; Taja Železnik Ramuta; Peter Veranič; Mateja Erdani Kreft; Marjanca Starčič Erjavec
Journal:  Microorganisms       Date:  2022-04-07

8.  Commentary: Comparative Analysis of Phylogenetic Assignment of Human and Avian ExPEC and Fecal Commensal Escherichia coli Using the (Previous and Revised) Clermont Phylogenetic Typing Methods and its Impact on Avian Pathogenic Escherichia coli (APEC) Classification.

Authors:  Marjanca Starčič Erjavec; Luka Predojević; Darja Žgur-Bertok
Journal:  Front Microbiol       Date:  2017-10-12       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.